• 1. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 2. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 3. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 4. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 5. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002

Recent Advances in the Study of 4-Chloro-2-methylpyrimidine HCl (CAS: 1272758-33-4) and Its Applications in Chemical Biology and Pharmaceutical Research

4-Chloro-2-methylpyrimidine HCl (CAS: 1272758-33-4) is a key intermediate in the synthesis of various biologically active compounds, particularly in the development of pharmaceuticals targeting kinase inhibition and other therapeutic areas. Recent studies have highlighted its significance in medicinal chemistry due to its versatile reactivity and role as a building block for more complex molecules. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, applications, and potential in drug discovery.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers explored the use of 4-Chloro-2-methylpyrimidine HCl as a precursor for the synthesis of novel kinase inhibitors. The study demonstrated that this compound could be efficiently functionalized to yield derivatives with high selectivity for specific kinase targets, such as EGFR and BRAF, which are implicated in various cancers. The researchers employed a combination of computational modeling and experimental validation to optimize the synthetic pathways, achieving yields of over 85% in some cases.

Another significant advancement was reported in a 2024 paper in Bioorganic & Medicinal Chemistry Letters, where 4-Chloro-2-methylpyrimidine HCl was utilized in the development of antiviral agents. The study focused on modifying the pyrimidine core to enhance binding affinity to viral polymerases, resulting in compounds with potent activity against RNA viruses, including SARS-CoV-2. The findings suggest that this compound could serve as a valuable scaffold for future antiviral drug design.

Beyond its applications in drug discovery, 4-Chloro-2-methylpyrimidine HCl has also been investigated for its role in chemical biology. A recent preprint on bioRxiv detailed its use in the synthesis of fluorescent probes for tracking cellular kinase activity. The probes, derived from this compound, exhibited high specificity and minimal cytotoxicity, making them suitable for live-cell imaging studies. This innovation opens new avenues for understanding kinase signaling pathways in real time.

Despite these promising developments, challenges remain in the large-scale production and purification of 4-Chloro-2-methylpyrimidine HCl. A 2023 industry report by a leading chemical supplier highlighted the need for improved synthetic protocols to reduce byproducts and enhance scalability. Addressing these issues will be critical for meeting the growing demand for this compound in both academic and industrial settings.

In conclusion, 4-Chloro-2-methylpyrimidine HCl (CAS: 1272758-33-4) continues to be a focal point in chemical biology and pharmaceutical research. Its versatility as a synthetic intermediate and its potential in drug discovery underscore its importance in the field. Future studies should focus on optimizing its synthesis and expanding its applications, particularly in the development of targeted therapies and diagnostic tools.

• 898044-48-9(4-chloropyrimidine-2-carbonitrile)
• 3842-28-2(4-Chloro-2-(chloromethyl)pyrimidine)
• 14331-51-2(4-chloro-2-ethylpyrimidine)
• 179051-78-6(4-Chloropyrimidine Hydrochloride (Technical Grade))
• 944902-13-0(4-chloropyrimidine-2-carbaldehyde)
• 17180-93-7(4-Chloropyrimidine)
• 1780-26-3(4,6-Dichloro-2-methylpyrimidine)
• 4994-86-9(4-Chloro-2-methylpyrimidine)
• 19875-05-9(4,6-Dichloro-2-(chloromethyl)pyrimidine)
• 89508-53-2(2,2'-Bipyrimidine, 4,6-dichloro-)